These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23242325)

  • 21. Outcome of haematopoietic stem cell transplantation in dyskeratosis congenita.
    Fioredda F; Iacobelli S; Korthof ET; Knol C; van Biezen A; Bresters D; Veys P; Yoshimi A; Fagioli F; Mats B; Zecca M; Faraci M; Miano M; Arcuri L; Maschan M; O'Brien T; Diaz MA; Sevilla J; Smith O; Peffault de Latour R; de la Fuente J; Or R; Van Lint MT; Tolar J; Aljurf M; Fisher A; Skorobogatova EV; Diaz de Heredia C; Risitano A; Dalle JH; Sedláček P; Ghavamzadeh A; Dufour C
    Br J Haematol; 2018 Oct; 183(1):110-118. PubMed ID: 29984823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulmonary fibrosis associated with TINF2 gene mutation: is somatic reversion required?
    Kannengiesser C; Borie R; Revy P
    Eur Respir J; 2014 Jul; 44(1):269-70. PubMed ID: 24982060
    [No Abstract]   [Full Text] [Related]  

  • 23. A de novo TINF2, R282C Mutation in a Case of Dyskeratosis Congenital Founded by Next-Generation Sequencing.
    Khakzad M; Shahbazi Z; Naderi M; Karimipoor M
    Iran Biomed J; 2023 Mar; 27(2 & 3):146-51. PubMed ID: 37070599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fatal diffuse capillaritis after hematopoietic stem-cell transplantation for dyskeratosis congenita despite low-intensity conditioning regimen.
    Brazzola P; Duval M; Fournet JC; Gauvin F; Dalle JH; Champagne J; Champagne MA
    Bone Marrow Transplant; 2005 Dec; 36(12):1103-5; author reply 1105. PubMed ID: 16205731
    [No Abstract]   [Full Text] [Related]  

  • 25. A unique case of coats plus syndrome and dyskeratosis congenita in a patient with CTC1 mutations.
    Han E; Patel NA; Yannuzzi NA; Laura DM; Fan KC; Negron CI; Prakhunhungsit S; Thorson WL; Berrocal AM
    Ophthalmic Genet; 2020 Aug; 41(4):363-367. PubMed ID: 32543263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita.
    Vulliamy TJ; Knight SW; Mason PJ; Dokal I
    Blood Cells Mol Dis; 2001; 27(2):353-7. PubMed ID: 11259155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ataxia and pancytopenia caused by a mutation in TINF2.
    Tsangaris E; Adams SL; Yoon G; Chitayat D; Lansdorp P; Dokal I; Dror Y
    Hum Genet; 2008 Dec; 124(5):507-13. PubMed ID: 18979121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A reduced intensity conditioning regimen of fludarabine, cyclophosphamide, antithymocyte globulin, plus 2 Gy TBI facilitates successful hematopoietic cell engraftment in an adult with dyskeratosis congenita.
    Kharfan-Dabaja MA; Otrock ZK; Bacigalupo A; Mahfouz RA; Geara F; Bazarbachi A
    Bone Marrow Transplant; 2012 Sep; 47(9):1254-5. PubMed ID: 22246089
    [No Abstract]   [Full Text] [Related]  

  • 29. Association of IL-1β -511 polymorphism with severe veno-occlusive disease in pediatric-matched allogeneic hematopoietic stem cell transplantation.
    Elbahlawan L; McArthur J; Quasney MW; Pei D; Srivastava K; Dahmer MK; Barfield R
    J Pediatr Hematol Oncol; 2012 Apr; 34(3):175-9. PubMed ID: 22395218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel missense mutation in the DKC1 gene in a Japanese family with X-linked dyskeratosis congenita.
    Hiramatsu H; Fujii T; Kitoh T; Sawada M; Osaka M; Koami K; Irino T; Miyajima T; Ito M; Sugiyama T; Okuno T
    Pediatr Hematol Oncol; 2002 Sep; 19(6):413-9. PubMed ID: 12186364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allogeneic hematopoietic stem cell transplantation for pediatric patients with treatment-related myelodysplastic syndrome or acute myelogenous leukemia.
    Kobos R; Steinherz PG; Kernan NA; Prockop SE; Scaradavou A; Small TN; Shukla N; Khalaf R; O'Reilly RJ; Boulad F
    Biol Blood Marrow Transplant; 2012 Mar; 18(3):473-80. PubMed ID: 22079789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dyskeratosis congenita: advances in the understanding of the telomerase defect and the role of stem cell transplantation.
    de la Fuente J; Dokal I
    Pediatr Transplant; 2007 Sep; 11(6):584-94. PubMed ID: 17663679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Status epilepticus as a main manifestation of posterior reversible encephalopathy syndrome after pediatric hematopoietic stem cell transplantation.
    Cordelli DM; Masetti R; Bernardi B; Barcia G; Gentile V; Biagi C; Prete A; Pession A; Franzoni E
    Pediatr Blood Cancer; 2012 May; 58(5):785-90. PubMed ID: 21990274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation.
    Nakamae H; Yamane T; Hasegawa T; Nakamae M; Terada Y; Hagihara K; Ohta K; Hino M
    Am J Hematol; 2006 Jul; 81(7):525-31. PubMed ID: 16755559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allogeneic Hematopoietic Cell Transplantation for Dyskeratosis Congenita: A Report of 3 Cases.
    Tamura S; Imamura T; Urata T; Kobayashi M; Gen M; Tomii T; Do J; Osone S; Ishida H; Hosoi H; Kuroda H
    J Pediatr Hematol Oncol; 2017 Oct; 39(7):e394-e398. PubMed ID: 28538506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Truncating TINF2 p.Tyr312Ter variant and inherited breast cancer susceptibility.
    Koivuluoma S; Vorimo S; Mattila TM; Tervasmäki A; Kumpula T; Kuismin O; Winqvist R; Moilanen J; Mantere T; Pylkäs K
    Fam Cancer; 2023 Jan; 22(1):13-17. PubMed ID: 35590014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predisposing factors of posterior reversible encephalopathy syndrome in acute childhood leukemia.
    Kim SJ; Im SA; Lee JW; Chung NG; Cho B; Kim HK; Lee IG
    Pediatr Neurol; 2012 Dec; 47(6):436-42. PubMed ID: 23127265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia].
    Liu QF; Sun J; Zhang Y; Liu XL; Xu D; Xu B; Feng R; Meng FY; Zhou SY
    Ai Zheng; 2004 Apr; 23(4):426-9. PubMed ID: 15087032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complete resolution of transplantation-associated thrombotic microangiopathy and hepatic veno-occlusive disease by defibrotide and plasma exchange.
    Beşişik SK; Oztürk GB; Calişkan Y; Sargin D
    Turk J Gastroenterol; 2005 Mar; 16(1):34-7. PubMed ID: 16252186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome.
    Willems L; Porcher R; Lafaurie M; Casin I; Robin M; Xhaard A; Andreoli AL; Rodriguez-Otero P; Dhedin N; Socié G; Ribaud P; Peffault de Latour R
    Biol Blood Marrow Transplant; 2012 Aug; 18(8):1295-301. PubMed ID: 22387347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.